The Addition of α-Hydroxy-benzylphosphonates to Dialkyl Acetylenedicarboxylates; Catalytic Hydrogenation of the Adducts
Synthesis · 01.10.2024 · 56 (19) · 3074-3082
DOI: 10.1055/a-2352-7116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, erschienen am 01.10.2024. Verfasst von Mátyás Milen und 4 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Research, Development and Innovation Office, Hungary.
Abstract (Originalsprache)
α-Hydroxy-benzylphosphonates obtained by the Pudovik reaction of substituted benzaldehydes and dialkyl phosphites were added to the triple bond of dialkyl acetylenedicarboxylates. Optimum conditions involved a 24 hours stirring in the presence of 10% diazabicycloundecene in dichloromethane to afford the adducts as a mixture of predominant E- and a minor Z-isomers in 75–90% yields after flash chromatography. The structures of the geometrical isomers were confirmed by NOE- and ROE-measurements. Catalytic hydrogenation of the olefinic moiety of the adducts led to the diastereoisomers of corresponding saturated derivatives.
Förderung
- National Research, Development and Innovation Office, Hungary
Zitieren
APA
Milen, M., Keglevich, G., Bese, C., Kovács, C., & Dancsó, A. (2024). The Addition of α-Hydroxy-benzylphosphonates to Dialkyl Acetylenedicarboxylates; Catalytic Hydrogenation of the Adducts. Synthesis, 56(19), 3074-3082. https://doi.org/10.1055/a-2352-7116
Vancouver
Milen M, Keglevich G, Bese C, Kovács C, Dancsó A. The Addition of α-Hydroxy-benzylphosphonates to Dialkyl Acetylenedicarboxylates; Catalytic Hydrogenation of the Adducts. Synthesis. 2024;56(19):3074-3082. doi:10.1055/a-2352-7116
BibTeX
@article{Milen2024,
author = {Milen, Mátyás and Keglevich, György and Bese, Cintia and Kovács, Csenge and Dancsó, András},
title = {The Addition of α-Hydroxy-benzylphosphonates to Dialkyl Acetylenedicarboxylates; Catalytic Hydrogenation of the Adducts},
journal = {Synthesis},
year = {2024},
volume = {56},
number = {19},
pages = {3074--3082},
doi = {10.1055/a-2352-7116}
}
EUVIMED